Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02450305 · ClinicalTrials.gov registry record
Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 53
- Enrollment target
NCT02450305: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT02450305 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02450305 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
The investigators intend to determine if patients that are already undergoing Hyperbaric Oxygen (HBO) therapy one year post treatment with radiation therapy for head and neck cancer, experience improvement in xerostomia and/or taste alteration. The investigators will enroll a similar demographic one year post treatment with radiation therapy that does not receive HBO therapy. This is a quality of life study.
Primary Outcome
The improvement of xerostomia following HBO therapy will be measured using standard RTOG head and neck cancer questionnaires.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-08 |
| Est. Completion | 2022-01-19 |
What the finished NCT02450305 record still lists
NCT02450305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02450305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02450305 about?
NCT02450305 is a clinical study titled "Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects". The investigators intend to determine if patients that are already undergoing Hyperbaric Oxygen (HBO) therapy one year post treatment with radiation therapy for head and neck cancer, experience improvement in xerostomia and/or taste alteration. The investigators will enroll a similar demographic one...
What is the current status of trial NCT02450305?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2013-08. Estimated completion is 2022-01-19.
Who is sponsoring clinical trial NCT02450305?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia